Navigation Links
AtheroNova to Present at the 2013 Aegis Healthcare Conference in Las Vegas
Date:9/19/2013

IRVINE, Calif., Sept. 19, 2013 /PRNewswire/ -- AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced that Chairman and CEO, Thomas W. Gardner, will present a corporate overview at the 2013 Aegis Capital Healthcare Conference. The presentation will take place at 9:00am PT on Saturday, September 28 at The Encore at Wynn in Las Vegas, NV.

In addition to the presentation, Mr. Gardner will be available to meet with analysts, industry executives and investors in one-on-one meetings.  Those interested in meeting with Mr. Gardner during the Conference are encouraged to contact the Company directly at info@atheronova.com.

About AtheroNova

AtheroNova Inc. is a biotechnology company focused on the discovery, research, development and licensing of novel compounds to safely reduce or regress atherosclerotic plaque deposits and improve lipid profiles in humans. In addition to its lead compound AHRO-001, AtheroNova plans to develop multiple applications for its patented and patents-pending therapies in market sectors that include: Cardiovascular Disease, Stroke, Peripheral Artery Disease, Dementia and Alzheimer's and Erectile Dysfunction, all of which have been linked to atherosclerosis. Atherosclerosis and its related pharmaceutical expenses for these indications cost consumers more than $41 billion annually in the United States alone. For more information, please visit www.AtheroNova.com.

Forward-Looking Statements

This news release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statemen
'/>"/>

SOURCE AtheroNova Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
2. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
3. AtheroNova Announces a New Board Member
4. AtheroNova Achieves Milestone in Initiating First Shipment of AHRO-001
5. AtheroNova Releases 2011 Financial Results
6. AtheroNova to Present at Rodman & Renshaw 14th Annual Healthcare Conference in New York City
7. AtheroNova Names New Director
8. AtheroNova Receives Notice of Issuance of Its U.S. Patent 8,304,383
9. AtheroNova Adds New Medical Advisor
10. Noted Atherosclerosis Researcher Joins AtheroNova Team
11. AtheroNova Announces Approval for Phase 1 by the Russian Ministry of Healthcare with Commencement of Human Trials Imminent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014 Rancho BioSciences ... integration of Omicsoft’s Array Suite with tranSMART . ... be able to send data in tranSMART to Array ... all versions of tranSMART including the new 1.2 release. ... visualization and storage for the analysis of high dimensional ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 “Rapid ... automation across the U.S., increasing unemployment, depressing American ... It is a Catch 22—we need automated ... this means fewer jobs,” says economist and corporate ... Pollina Corporate Top 10 Pro-Business States for 2014, ...
(Date:7/31/2014)... The Kidney Cancer Association (KCA) has established a ... Kidney Cancer News. , Bill Bro, KCA CEO, says, ... by an international news organization. When we began using iReport ... This month’s program highlights news of an enzyme that is ... recent study. Kidney Cancer News also presents a report on ...
(Date:7/30/2014)... July 30, 2014 Regulus Therapeutics Inc ... leading the discovery and development of innovative medicines targeting ... and highlights for the quarter ended June 30, 2014 ... markets close. Regulus will host a ... at 5:00 pm Eastern Daylight Time to discuss its ...
Breaking Biology Technology:Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART 2Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART 3ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 2ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 3ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 4Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3
... , MENLO PARK, Calif., Sept. 21 ForteBio(R), Inc., ... biotherapeutic and pharmaceutical products, announced today that Joseph D. Keegan, Ph.D., ... Global Life Sciences Conference on Wednesday, September 23, 2009. His presentation ... Grand Hyatt Hotel in New York City. , , ...
... NEW YORK, Sept. 21 Emissary Capital ... Inc. (OTC Bulletin Board: SNBP) with a Buy rating ... known domestically as Dong Ying Pharmaceutical Co. Ltd., is ... the R&D, manufacture and distribution of biopharmaceutical products. ...
... , SOUTH BEND, Ind., Sept. 21 ... program offering feedback directly to patients regarding their imaging tests within ... noted that in many cases, patients will actually get their test ... results program include diagnostic mammograms, general X-rays and bone density tests, ...
Cached Biology Technology:Emissary Capital Group Initiates Coverage on Sinobiopharma 2XRC Medical Imaging Announces Rapid Test Results 2
(Date:7/31/2014)... A hidden hazard lurks beneath many of the ... , The hazard is corrosion in parts of ... failures, leaks and contamination of groundwater, a source ... in nine states have reported many rapidly corroding ... These incidents are generally associated with use of ...
(Date:7/31/2014)... Neb., July 31, 2014 -- Do people make a ... mothers raise them that way? Is it a matter ... Nebraska-Lincoln and a colleague from Rice University say that ... some people lean left while others lean right. , ... and deep-seated psychology are at the core of political ...
(Date:7/31/2014)... conflagration known as the Rim Fire was in full ... trees, when it entered the backcountry of Yosemite National ... But inside the park, the battle began to turn, ... and drought can combine to fuel large, severe fires. ... eventually encountered lands where fire had been used as ...
Breaking Biology News(10 mins):NIST corrosion lab tests suggest need for underground gas tank retrofits 2Scientists find growing consensus: Political attitudes derive from body and mind 2The Rim Fire 1 year later: A natural experiment in fire ecology and management 2The Rim Fire 1 year later: A natural experiment in fire ecology and management 3The Rim Fire 1 year later: A natural experiment in fire ecology and management 4The Rim Fire 1 year later: A natural experiment in fire ecology and management 5
... blind cave shrimp, and other oddities suggest a "use ... microbial world, an unusual marine microorganism appears to have ... remarkably reduced set of genes. This metabolic ... very important function: taking nitrogen gas from the atmosphere ...
... common gene variant associated with a form of the irregular ... journal Nature Genetics , being published online, the investigators ... control the heart,s electrical activity appear to increase the risk ... seen in younger individuals with no other form of heart ...
... Jacques Cousteau as the "world,s aquarium," the marine ecosystems ... new fishing methods are depleting the sea,s habitats, creating ... Scripps explorations story "Threatened Gulf" . But, ... UC San Diego will describe during a presentation at ...
Cached Biology News:Genome analysis of marine microbe reveals a metabolic minimalist 2Genome analysis of marine microbe reveals a metabolic minimalist 3Common gene variant may increase risk for a type of cardiac arrhythmia 2Damage to threatened Gulf of California habitats can be reversed 2
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
Chicken polyclonal to QPRT ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to Internal sequence amino acids 123-237 of Human QPRT Entrez Gene ID: 23475 ...
...
Antibody Diluent for IHC 125 ml...
Biology Products: